NAFDAC

  • Increase font size
  • Default font size
  • Decrease font size
Home Pharmacovigilance / FDIC Pharmacovigilance / FDIC Newsletter
Pharmacovigilance / FDIC Newsletter
Pharmacovigilance / FDIC

DocumentsDate added

Order by : Name | Date | Hits [ Ascendant ]
This edition highlights salient issues such as the update on Cohort Event Monitoring study on the use of Artemisinin Combination Therapy{ACTs} in selected hospitals in all regions of Nigeria with emphasis on WHO\UMC visit to the NPC, report of adverse drug reactions (ADR) attributed to tramadol, an opioid analgesic, prescribed by medical practitioners in Nigerian hospitals. It also features a compilation of adverse reaction reports of interest and pharmacovigilance news from other countries as reported in Reaction Weekly. Kindly acknowledge through e-mail the receipt of this newsletter and of course your comments are most useful and welcome
This edition highlights salient issues such as the reported deaths associated with the
pediatric use of contaminated teething mixture. Other issues of discuss include the
Cohort Event Monitoring study on the use of Artemisinin Combination Therapy{ACTs} in
Nigeria and a public alert on contamination of Chinese milk products with melamine. It
also features a compilation of adverse reaction reports of interest and pharmacovigilance
news from other countries. We look forward to your comments and feedback.